Tags:
oncology market intelligence, Pharma M&A, Healthcare Investment, KOL Insights, Physician Adoption Forecasting, Clinical Adoption Intelligence,, Oncology Asset Valuation
Learn how expert-led oncology market intelligence helped a private equity firm identify a 25% revenue projection gap before completing a $300M oncology acquisition. This blog explores physician adoption forecasting, KOL insights, and healthcare investment due diligence strategies used to reduce commercial risk and improve acquisition confidence.




